Kivelä T
Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland.
J Clin Oncol. 1999 Jun;17(6):1829-37. doi: 10.1200/JCO.1999.17.6.1829.
To obtain refined knowledge regarding trilateral retinoblastoma (TRb), which is a syndrome that consists of hereditary retinoblastoma associated with an intracranial neuroblastic tumor.
Using a systematic literature review, we contacted authors to obtain missing information. Data from 106 children were used in a meta-analysis including frequency distributions and Kaplan-Meier survival curves.
TRb showed no sex predilection. Median age at diagnosis of retinoblastoma was 5 months (range, 0 to 29 months); age at diagnosis was younger among 47 children (47%) with familial retinoblastoma compared with age at diagnosis among 52 children (53%) with sporadic retinoblastoma (2 v 6.5 months, P <.0001). TRb usually affected the second or third generation with retinoblastoma. Median time from retinoblastoma to TRb was 21 months (range, 6 months before to 141 months after); time to TRb was longer for 78 (77%) pineal tumors compared with 23 (23%) suprasellar tumors (32 v 6.5 months, P <.0001). The size (27 v 32 mm, P =.57) and prognosis (survival of 9 v 8 months, P =.91) of pineal and suprasellar tumors were similar. TRb was detected earlier (1 v 22 months, P =.0007) and the child survived longer if neuroimaging was routinely performed (16 v 8 months, P =.001), but age at death was similar (36 v 37 months, P =.98). Cumulative 5-year survival (which was likely to indicate cure) was 27% (v 0%) if screening was undertaken. All children whose TRb exceeded 15 mm in size died.
The family history, age at diagnosis, and laterality of retinoblastoma in children with TRb resembled that of ordinary hereditary retinoblastoma. Suprasellar TRb were diagnosed earlier, and may arise earlier, than pineal TRb. Screening by neuroimaging could improve the cure rate if cases of TRb were detected when tumors were 15 mm or smaller in size.
获取有关三边性视网膜母细胞瘤(TRb)的精确知识,TRb是一种由遗传性视网膜母细胞瘤与颅内神经母细胞瘤组成的综合征。
采用系统文献综述,我们联系作者以获取缺失信息。106名儿童的数据用于荟萃分析,包括频率分布和Kaplan-Meier生存曲线。
TRb无性别倾向。视网膜母细胞瘤诊断时的中位年龄为5个月(范围0至29个月);47名(47%)家族性视网膜母细胞瘤患儿的诊断年龄比52名(53%)散发性视网膜母细胞瘤患儿的诊断年龄小(2个月对6.5个月,P<.0001)。TRb通常累及视网膜母细胞瘤的第二代或第三代。从视网膜母细胞瘤到TRb的中位时间为21个月(范围,视网膜母细胞瘤诊断前6个月至诊断后141个月);78例(77%)松果体肿瘤发生TRb的时间比23例(23%)鞍上肿瘤长(32个月对6.5个月,P<.0001)。松果体和鞍上肿瘤的大小(27mm对32mm,P=.57)和预后(生存9个月对8个月,P=.91)相似。如果常规进行神经影像学检查,TRb能被更早发现(1个月对22个月,P=.0007),患儿存活时间更长(16个月对8个月,P=.001),但死亡年龄相似(36个月对37个月,P=.98)。如果进行筛查,累积5年生存率(可能表明治愈)为27%(对0%)。所有TRb大小超过15mm的儿童均死亡。
TRb患儿的家族史、诊断年龄和视网膜母细胞瘤的侧别与普通遗传性视网膜母细胞瘤相似。鞍上TRb比松果体TRb诊断更早,可能出现也更早。如果在TRb肿瘤大小为15mm或更小的时候进行检测,通过神经影像学筛查可提高治愈率。